SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0000950170-23-067043
Filing Date
2023-11-30
Accepted
2023-11-30 16:18:36
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 2023-11-29-final_prosupp.htm 424B5 1011730
2 EX-FILING FEES xene-exfiling_fees.htm EX-FILING FEES 43346
3 GRAPHIC img42685311_0.jpg GRAPHIC 10797
4 GRAPHIC img42685311_1.jpg GRAPHIC 10838
5 GRAPHIC img42685311_2.jpg GRAPHIC 10797
  Complete submission text file 0000950170-23-067043.txt   1101128
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-260010 | Film No.: 231456098
SIC: 2834 Pharmaceutical Preparations